Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: Neurocrit Care. 2012 Dec;17(3):441–467. doi: 10.1007/s12028-012-9747-4

Table 2.

Evidence-based summary of biomarkers used in anoxic encephalopathy

References LOE
Brain biomarkers
 Neuron-specific enolase (NSE) [114, 166-172] 4,5
 S-100B [166, 173, 174] 5
 Glia fibrillary acidic protein (GFAP) [175] 5
 Tau [176] 5
Cardiac biomarkers
 Cardiac troponin I [165] 4
 Cardiac troponin T
 Micro-RNA [181]
Non-specific biomarkers
 Plasma glucose [120, 123, 177] 3,4
 Lactate [13, 178] 4
 Pro-calcitonin [179, 180] 5

All level of evidence (LOE) 3 (studies using retrospective controls) and LOE 4 (studies without a control group (e.g., case series)) investigations were performed on drowning victims. LOE 5 (studies not directly related to the specific patient/population) investigations were performed on cardiac arrest patients